Browse by Person

Up a level
Export as [feed] RSS 2.0 [feed] RSS 1.0 [feed] Atom
Group by: Item Type | Date | No Grouping
2012 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000
Number of items: 24.

2012

Abuirmeileh, A., Harkavyi, A., Rampersaud, N., Lever, R., Tadross, J.A., Bloom, S.R. and Whitton, P.S. (2012) Exendin-4 treatment enhances L-DOPA evoked release of striatal dopamine and decreases dyskinetic movements in the 6-hydoxydopamine lesioned rat. Journal of Pharmacy and Pharmacology, 64 (5). pp. 637-643. /10.1111/j.2042-7158.2011.01394.x.

Lever, R. and Page, C.P. (2012) Non-anticoagulant Effects of Heparin: An Overview. In: Heparin - A Century of Progress. Handbook of Experimental Pharmacology (207). Springer, pp. 281-305. 10.1007/978-3-642-23056-1_12.

2010

Zelmer, A., Martin, M.J., Gundogdu, O., Birchenough, G., Lever, R., Wren, B.W., Luzio, J.P. and Taylor, P.W. (2010) Administration of capsule-selective endosialidase E minimizes upregulation of organ gene expression induced by experimental systemic infection with Escherichia coli K1. Microbiology, 156 (7). pp. 2205-2215. 10.1099/mic.0.036145-0.

Lever, R., Smailbegovic, A. and Page, C.P. (2010) Locally available heparin modulates inflammatory cell recruitment in a manner independent of anticoagulant activity. European Journal of Pharmacology, 630 (1-3). pp. 137-144. 10.1016/j.ejphar.2009.12.015 .

2009

Abuirmeileh, A., Harkavyi, A., Kingsbury, A.E., Lever, R. and Whitton, P.S. (2009) The CRF-like peptide urocortin greatly attenuates loss of extracellular striatal dopamine in rat models of Parkinson's disease by activating CRF1 receptors. European Journal of Pharmacology, 604 (1-3). pp. 45-50. 10.1016/j.ejphar.2008.11.009.

2008

Harkavyi, A., Abuirmeileh, A., Lever, R., Kingsbury, A.E., Biggs, C.S. and Whitton, P.S. (2008) Glucagon-like peptide 1 receptor stimulation by exendin-4 reverses key deficits in distinct rodent models of Parkinson's disease. Journal of Neuroinflammation, 5 (1). p. 19. 10.1186/1742-2094-5-19.

Abuirmeileh, A., Harkavyi, A., Kingsbury, A.E., Lever, R. and Whitton, P.S. (2008) The CRF-like peptide urocortin produces a long-lasting recovery in rats made hemiparkinsonian by 6-hydroxydopamine or lipopolysaccharide. Journal of the Neurological Sciences, 271 (1-2). pp. 131-136.

2007

Lever, R., Hefni, A., Moffatt, J.D., Paul, W. and Page, C.P. (2007) Effect of tecastemizole on pulmonary and cutaneous allergic inflammatory responses. Clinical & Experimental Allergy, 37 (6). p. 909. 10.1111/j.1365-2222.2007.02730.x.

Lever, R., Lo, W.T., Faraidoun, M., Amin, V., Brown, R.A., Gallagher, J. and Page, C.P. (2007) Size-fractionated heparins have differential effects on human neutrophil functionin vitro. British Journal of Pharmacology, 151 (6). p. 837. 10.1038/sj.bjp.0707298.

Abuirmeileh, A., Lever, R., Kingsbury, A.E., Lees, A.J., Locke, I.C., Knight, R.A., Chowdrey, H.S., Biggs, C.S. and Whitton, P.S. (2007) The corticotrophin-releasing factor-like peptide urocortin reverses key deficits in two rodent models of Parkinson's disease. European Journal of Neuroscience, 26 (2). pp. 417-423. 10.1111/j.1460-9568.2007.05653.x.

Abuirmeileh, A., Harkavyi, A., Lever, R., Biggs, C.S. and Whitton, P.S. (2007) Urocortin, a CRF-like peptide, restores key indicators of damage in the substantia nigra in a neuroinflammatory model of Parkinson's disease. Journal of Neuroinflammation, 4 (1). p. 19. 10.1186/1742-2094-4-19.

2006

Moffatt, J.D., Lever, R. and Page, C.P. (2006) Activation of corticotropin-releasing factor receptor-2 causes bronchorelaxation and inhibits pulmonary inflammation in mice. FASEB Journal, 20 (11). p. 1877. 10.1096/fj.05-5315fje.

2005

Jones, N.A., Boswell-Smith, V., Lever, R. and Page, C.P. (2005) The effect of selective phosphodiesterase isoenzyme inhibition on neutrophil function in vitro. Pulmonary Pharmacology & Therapeutics, 18 (2). pp. 93-101. 10.1016/j.pupt.2004.10.001.

2004

Bavington, C.D., Lever, R., Mulloy, B., Grundy, M.M., Page, C.P., Richardson, N.V. and McKenzie, J.D. (2004) Anti-adhesive glycoproteins in echinoderm mucus secretions. Comparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology, 139 (4). pp. 607-617. 10.1016/j.cbpc.2004.07.008.

Moffatt, J.D., Lever, R. and Page, C.P. (2004) Effects of inhaled thrombin receptor agonists in mice. British Journal of Pharmacology, 143 (2). pp. 269-275. 10.1038/sj.bjp.0705926.

Johnson, Z., Kosco-Vilbois, M.H., Herren, S., Cirillo, R., Muzio, V., Zaratin, P., Carbonatto, M., Mack, M., Smailbegovic, A., Rose, M., Lever, R., Page, C.P., Wells, T.N.C. and Proudfoot, A.E I. (2004) Interference with heparin binding and oligomerization creates a novel anti-inflammatory strategy targeting the chemokine system. Journal of Immunology, 173 (9). pp. 5776-5785.

2003

Brown, R.A., Lever, R., Jones, N.A. and Page, C.P. (2003) Effects of heparin and related molecules upon neutrophil aggregation and elastase releasein vitro. British Journal of Pharmacology, 139 (4). pp. 845-853. 10.1038/sj.bjp.0705291.

Pitchford, S., Yano, H., Lever, R., Riffovasquez, Y., Ciferri, S., Rose, M., Gianni, S., Momi, S., Spina, D. and OConnor, B. (2003) Platelets are essential for leukocyte recruitment in allergic inflammation. Journal of Allergy and Clinical Immunology, 112 (1). pp. 109-118. 10.1067/mai.2003.1514.

2002

Lever, R. and Page, C.P. (2002) Novel drug development opportunities for Heparin. Nature Reviews. Drug discovery, 1 (2). pp. 140-148. 10.1038/nrd724.

2001

Lever, R. and Page, C.P. (2001) Glycosaminoglycans, Airways Inflammation and Bronchial Hyperresponsiveness. Pulmonary Pharmacology & Therapeutics, 14 (3). p. 249. 10.1006/pupt.2001.0296.

Lever, R., Smailbegovic, A. and Page, C.P. (2001) Role of glycosaminoglycans in inflammation. InflammoPharmacology, 9 (1-2). pp. 165-169. 10.1163/156856001300248443.

Smailbegovic, A., Lever, R. and Page, C.P. (2001) The effects of heparin on the adhesion of human peripheral blood mononuclear cells to human stimulated umbilical vein endothelial cells. British Journal of Pharmacology, 134 (4). p. 827. 10.1038/sj.bjp.0704321.

2000

Lever, R. (2000) HIT dynamics are Fab. Trends in Pharmacological Sciences, 21 (9). p. 330. 10.1016/S0165-6147(00)01529-7.

Lever, R., Hoult, J.R.S. and Page, C.P. (2000) The effects of heparin and related molecules upon the adhesion of human polymorphonuclear leucocytes to vascular endotheliumin vitro. British Journal of Pharmacology, 129 (3). pp. 533-540. 10.1038/sj.bjp.0703099.

This list was generated on Thu Oct 23 14:06:06 2014 BST.